Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1983 Apr 15;212(1):129–134. doi: 10.1042/bj2120129

Novel prostaglandin dehydrogenase in rat skin.

N Fincham, R Camp
PMCID: PMC1152019  PMID: 6575778

Abstract

Present evidence suggests that skin is an important organ of prostaglandin metabolism. To clarify its role, the basic kinetics of 15-hydroxyprostaglandin dehydrogenase (PGDH) from rat skin were investigated with either NAD+ of NADP+ as co-substrate. Prostaglandin F2 alpha (PGF2 alpha) and prostaglandin E2 (PGE2) were used as substrates and preliminary studies were made of the inhibitory effects of the reduced co-substrates NADH and NADPH. A radiochemical assay was used in which [3H]PGF2 alpha or [14C]PGE2 were incubated with high-speed supernatant of rat skin homogenates. The substrate and products were then extracted by solvent partition, separated by t.l.c. and quantified by liquid-scintillation counting. At linear reaction rates and at an NAD+ concentration of 10 mM the mean apparent Km for PGF2 alpha was 24 microM with a mean apparent Vmax. of 9.8 nmol/s per litre of reaction mixture. For PGE2 the mean apparent Km was 8 microM, with a mean apparent Vmax, of 2.7 nmol/s per litre of reaction mixture. With NADP+ as a co-substrate at a concentration of 5 mM a mean apparent Km of 23 microM was obtained for PGF2 alpha with a mean apparent Vmax. of 5.2 nmol/s per litre. For PGE2 values of 7.5 microM and 3.0 nmol/s per litre were obtained respectively. These results show that skin contains NAD+- and NADP+-dependent PGDH. An important finding was that the NADP+-linked enzyme gave Km values for PGE2 that were considerably lower than those reported for NADP+-linked PGDH from other tissues. Furthermore, preliminary inhibition studies with the NAD+-linked PGDH system indicate that this enzyme is not only inhibited by NADH, but also by NADPH, a property not previously reported for NAD+-linked PGDH derived from other tissues.

Full text

PDF
129

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anders N. H. Preparative thin-layer and column chromatography of prostaglandins. J Lipid Res. 1969 May;10(3):316–319. [PubMed] [Google Scholar]
  2. Anggård E., Larsson C., Samuelsson B. The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-delta 13-reductase in tissues of the swine. Acta Physiol Scand. 1971 Mar;81(3):396–404. doi: 10.1111/j.1748-1716.1971.tb04914.x. [DOI] [PubMed] [Google Scholar]
  3. Anggård E., Larsson C. The sequence of the early steps in the metabolism of prostaglandin E1. Eur J Pharmacol. 1971;14(1):66–70. doi: 10.1016/0014-2999(71)90123-3. [DOI] [PubMed] [Google Scholar]
  4. Camp R. D. Prostaglandins, hydroxy fatty acids, leukotrienes and inflammation of the skin. Clin Exp Dermatol. 1982 Jul;7(4):435–444. doi: 10.1111/j.1365-2230.1982.tb02453.x. [DOI] [PubMed] [Google Scholar]
  5. Camp R., Greaves M. W. The catabolism of prostaglandins by rat skin. Biochem J. 1980 Jan 15;186(1):153–160. doi: 10.1042/bj1860153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hamberg M., Samuelsson B. Metabolism of prostaglandin E2 in guinea pig liver. II. Pathways in the formation of the major metabolites. J Biol Chem. 1971 Feb 25;246(4):1073–1077. [PubMed] [Google Scholar]
  7. Hanes C. S. Studies on plant amylases: The effect of starch concentration upon the velocity of hydrolysis by the amylase of germinated barley. Biochem J. 1932;26(5):1406–1421. doi: 10.1042/bj0261406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hansen H. S. 15-hydroxyprostaglandin dehydrogenase. A review. Prostaglandins. 1976 Oct;12(4):647–679. doi: 10.1016/0090-6980(76)90044-7. [DOI] [PubMed] [Google Scholar]
  9. Jarabak J., Fried J. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases. Prostaglandins. 1979 Aug;18(2):241–246. doi: 10.1016/0090-6980(79)90109-6. [DOI] [PubMed] [Google Scholar]
  10. Kaplan L., Lee S. C., Levine L. Partial purification and some properties of human erythrocyte prostaglandin 9-ketoreductase and 15-hydroxyprostaglandin dehydrogenase. Arch Biochem Biophys. 1975 Mar;167(1):287–293. doi: 10.1016/0003-9861(75)90464-6. [DOI] [PubMed] [Google Scholar]
  11. Lee S. C., Levine L. Prostaglandin metabolism. II. Identification of two 15-hydroxyprostaglandin dehydrogenase types. J Biol Chem. 1975 Jan 25;250(2):548–552. [PubMed] [Google Scholar]
  12. Rückrich M. F., Wendel A., Schlegel W., Jackisch R., Jung A. 15-Hydroxyprostaglandin-Dehydrogenase aus Humanplacenta, II[1] Steady State Kinetik und der Einfluss von Prostaglandin-F2alpha-Analogen. Hoppe Seylers Z Physiol Chem. 1975 Jun;356(6):799–809. [PubMed] [Google Scholar]
  13. Westbrook C., Lin Y. M., Jarabak J. NADP-linked 15-hydroxyprostaglandin dehydrogenase from human placenta: partial purification and characterization of the enzyme and identification of an inhibitor in placental tissue. Biochem Biophys Res Commun. 1977 Jun 6;76(3):943–949. doi: 10.1016/0006-291x(77)91593-5. [DOI] [PubMed] [Google Scholar]
  14. Wright J. T., Jr, Corder C. N. Effect of mercaptoethanol in the radioactive thin layer chromatography assay of NAD+-15-hydroxyprostaglandin in dehydrogenase. Prostaglandins. 1979 Mar;17(3):431–440. doi: 10.1016/s0090-6980(79)80011-8. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES